ARTV - Artiva Biotherapeutics, Inc.
11.3
-0.430 -3.805%
Share volume: 172,442
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.73
-0.43
-0.04%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 08-29-2024 | 11-12-2024 | 03-24-2025 | 05-08-2025 | 11-12-2025 | 03-10-2026 | |
| Assets | |||||||
| Total Assets | 75.912 M | 225.596 M | 209.581 M | 191.263 M | 148.862 M | 130.940 M | |
| Current Assets | 49.749 M | 150.565 M | 188.631 M | 170.004 M | 129.524 M | 112.666 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 12.308 M | 90.750 M | 145.193 M | 135.562 M | 97.460 M | 81.307 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 34.248 M | 55.881 M | 40.235 M | 30.401 M | 25.508 M | 26.701 M | |
| Total Non-current Assets | 0.000 | 52.966 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 7.315 M | 6.857 M | 6.370 M | 7.057 M | 6.981 M | 6.618 M | |
| Other Assets | 18.848 M | 68.174 M | 14.580 M | 14.202 M | 12.357 M | 11.656 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 75.912 M | 225.596 M | 209.581 M | 191.263 M | 148.862 M | 130.940 M | |
| Total liabilities | 50.596 M | 24.600 M | 22.940 M | 22.480 M | 19.638 M | 20.970 M | |
| Total current liabilities | 10.827 M | 13.292 M | 12.253 M | 12.204 M | 11.119 M | 13.087 M | |
| Accounts Payable | 823.000 K | 1.215 M | 1.121 M | 2.036 M | 848.000 K | 355.000 K | |
| Other liabilities | 39.663 M | 11.233 M | 10.643 M | 10.265 M | 8.519 M | 7.883 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 39.663 M | 11.233 M | 10.643 M | 10.265 M | 8.519 M | 7.883 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -191.097 M | 200.996 M | 186.641 M | 168.783 M | 129.224 M | 109.970 M | |
| Common stock | 21.899 M | 431.247 M | 433.454 M | 435.778 M | 438.914 M | 440.416 M | |
| Retained earnings | -213.117 M | -230.589 M | -246.684 M | -266.995 M | -309.777 M | -330.549 M |